Skip to main content

Advertisement

SpringerLink
Log in

Molecular modelling studies on flavonoid derivatives as dual site inhibitors of human acetyl cholinesterase using 3D-QSAR, pharmacophore and high throughput screening approaches

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

Alzheimer’s disease (AD) is a multi-factorial neurodegenerative disease that affects millions of elderly people worldwide. Due to its massive occurrence and severity, there is continuing and compelling need for the development of novel and effective drugs for improved treatment of AD. Since AD is characterized by the deficiency in cholinergic neurotransmission, acetyl cholinesterase (AChE) has been considered as a promising drug target. Herein we triggered our effort to design novel and potential inhibitors of AChE using a set of 24 flavonoid compounds having inhibitory activity against AChE. We carried out 3D-QSAR-based and pharmacophore-based identification of novel natural lead candidates. The 3D-QSAR model obtained using partial least square regression showed satisfactory parametric values (r 2 = 0.8227, q 2 = 0.6833 and pred-r 2 = 0.7893). Amongst total 14 pharmacophore hypothesis generated the one possessing following five features: one hydrogen bond acceptor, two hydrophobic regions and two aromatic rings, was considered to be the best pharmacophore hypothesis. Above-described robust and validated 3D-QSAR and pharmacophore models were used for carrying out prospective generic prediction and virtual screening on large natural compound libraries. The screened molecules from both the approaches were subjected for further docking analysis to reveal the binding modes of actions of these ligands. All the ligands were found to bind with both catalytic and anionic subsite of AChE. The molecular insights obtained from this study will be of high value for design and development of novel drugs for AD, possessing improved binding properties and low toxicity to human.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Afantitis A, Melagraki G, Sarimveis H, Igglessi-Markopoulou O, Kollias G (2009) A novel QSAR model for predicting the inhibition of CXCR3 receptor by 4-N-aryl-[1,4] diazepane ureas. Eur J Med Chem 44:877–884

    Article  CAS  PubMed  Google Scholar 

  • Agrawal R, Jain P, Dikshit SN (2012) Ligand-based pharmacophore detection, screening of potential gliptins and docking studies to get effective antidiabetic agents. Comb Chem High Throughput Screen 15:849–876

    Article  CAS  PubMed  Google Scholar 

  • Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–414

    Article  CAS  PubMed  Google Scholar 

  • Berriman J (2003) Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-structure. Proc Natl Acad Sci USA 100:9034–9038

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Bhole RP, Borkar DD, Bhusari KP, Patil PA (2012) Design and synthesis of p-hydroxybenzohydrazide derivatives for their antimycobacterial activity. J Korean Chem Soc 56:236–245

    Article  CAS  Google Scholar 

  • Brufani M, Castellano C, Marta M, Murroni F, Oliverio A, Pagella PG, Pavone F, Pomponi M, Rugarli PL (1988) From physostigmine derivatives as new inhibitors of cholinesterase. In: Giacobini E, Becker RE (eds) Current research in Alzheimer therapy. Taylor & Francis, p 10

  • Camps P, Formosa X, Galdeano C, Gomez T, Munoz-Torrero D, Scarpellini M, Viayna E, Badia A, Clos MV, Camins A et al (2008) Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation. J Med Chem 51:3588–3598

    Article  CAS  PubMed  Google Scholar 

  • Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959–5967

    Article  CAS  PubMed  Google Scholar 

  • Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739–1749

    Article  CAS  PubMed  Google Scholar 

  • Golbraikh A, Tropsha A (2002) Beware of q2! J Mol Graph Model 20:269–276

    Article  CAS  PubMed  Google Scholar 

  • He XC, Feng S, Wang ZF, Shi Y, Zheng S, Xia Y, Jiang H, Tang XC, Bai D (2007) Study on dual-site inhibitors of acetylcholinesterase: highly potent derivatives of bis- and bifunctional huperzine B. Bioorg Med Chem 15:1394–1408

    Article  CAS  PubMed  Google Scholar 

  • Inestrosa NC, Dinamarca MC, Alvarez A (2008) Amyloid–cholinesterase interactions. Implications for Alzheimer’s disease. FEBS J 275:625–632

    Article  CAS  PubMed  Google Scholar 

  • Irwin JJ, Shoichet BK (2005) ZINC–a free database of commercially available compounds for virtual screening. J Chem Inf Model 45:177–182

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Jung M, Park M (2007) Acetylcholinesterase inhibition by flavonoids from Agrimonia pilosa. Molecules 12:2130–2139

    Article  CAS  PubMed  Google Scholar 

  • Kim H, Park BS, Lee KG, Choi CY, Jang SS, Kim YH, Lee SE (2005) Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. J Agric Food Chem 53:8537–8541

    Article  CAS  PubMed  Google Scholar 

  • Kryger G, Silman I, Sussman JL (1999) Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs. Structure 7:297–307

    Article  CAS  PubMed  Google Scholar 

  • Lahiri DK, Farlow MR, Greig NH, Sambamurti K (2002) Current drug targets for Alzheimer’s disease treatment. Drug Dev Res 56:267–281

    Article  CAS  Google Scholar 

  • Leonetti F, Catto M, Nicolotti O, Pisani L, Cappa A, Stefanachi A, Carotti A (2008) Homo- and hetero-bivalent edrophonium-like ammonium salts as highly potent, dual binding site AChE inhibitors. Bioorg Med Chem 16:7450–7456

    Article  CAS  PubMed  Google Scholar 

  • Mathuranath PS, George A, Ranjith N, Justus S, Kumar MS, Menon R, Sarma PS, Verghese J (2012) Incidence of Alzheimer’s disease in India: a 10 years follow-up study. Neurol India 60:625–630

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Nayyar A, Monga V, Malde A, Coutinho E, Jain R (2007) Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines. Bioorg Med Chem 15:626–640

    Article  CAS  PubMed  Google Scholar 

  • Neve RL, McPhie DL, Chen Y (2000) Alzheimer’s disease: a dysfunction of the amyloid precursor protein(1). Brain Res 886:54–66

    Article  CAS  PubMed  Google Scholar 

  • Nowaczyk A, Kulig K (2012) QSAR studies on a number of pyrrolidin-2-one antiarrhythmic arylpiperazinyls. Med Chem Res 21:373–381

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Perry EK, Perry RH, Gibson PH, Blessed G, Tomlinson BE (1977) A cholinergic connection between normal aging and senile dementia in the human hippocampus. Neurosci Lett 6:85–89

    Article  CAS  PubMed  Google Scholar 

  • Piazzi L, Rampa A, Bisi A, Gobbi S, Belluti F, Cavalli A, Bartolini M, Andrisano V, Valenti P, Recanatini M (2003) 3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer’s disease therapy. J Med Chem 46:2279–2282

    Article  CAS  PubMed  Google Scholar 

  • Querfurth HW, Laferla FM (2010) Alzheimer’s Disease REPLY. N Engl J Med 362:1844–1845

    Article  CAS  Google Scholar 

  • Sahu NK, Shahi S, Sharma MC, Kohli DV (2011) QSAR studies on imidazopyridazine derivatives as PfPK7 inhibitors. Mol Simul 37:752–765

    Article  CAS  Google Scholar 

  • Schrodinger (2009). Schrodinger suite. LLC, New York, NY

  • Selkoe DJ (1999) Translating cell biology into therapeutic advances in Alzheimer’s disease. Nature 399:A23–A31

    Article  CAS  PubMed  Google Scholar 

  • Sheng R, Lin X, Zhang J, Chol KS, Huang WH, Yang B, He QJ, Hu YZ (2009) Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors. Bioorg Med Chem 17:6692–6698

    Article  CAS  PubMed  Google Scholar 

  • Słowiński T, Stefanowicz J, Wróbel MZ, Herold F, Mazurek A, Pluciński F, Mazurek AP, Wolska I (2013) Model structure–activity relationship studies of potential tropane 5HT1A, 5HT2A, and D2 receptor ligands. Med Chem Res 22:3148–3153

    Article  PubMed Central  PubMed  Google Scholar 

  • Smith DA (2009) Treatment of Alzheimer’s disease in the long-term-care setting. Am J Health Syst Pharm 66:899–907

    Article  CAS  PubMed  Google Scholar 

  • Verma J, Khedkar VM, Coutinho EC (2010) 3D-QSAR in drug design: a review. Curr Top Med Chem 10:95–115

    Article  CAS  PubMed  Google Scholar 

  • VLifeMDS: Molecular Design Suite (2010). Pune, India, VLife Sciences Technologies Pvt. Ltd

  • Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein–ligand interactions. Protein Eng 8:127–134

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

AG is thankful to Jawaharlal Nehru University for usage of all computational facilities. AG is grateful to University Grants Commission, India for the Faculty Recharge position.

Author information

Authors and Affiliations

  1. Apaji Institute of Mathematics and Applied Computer Technology, Banasthali University, Tonk, 304022, Rajasthan, India

    Manisha Goyal, Sukriti Goyal & Chetna Tyagi

  2. School of Biotechnology, Jawaharlal Nehru University, New Delhi, 110067, India

    Sonam Grover & Abhinav Grover

  3. Department of Biotechnology, Delhi Technological University, New Delhi, 110042, India

    Jaspreet Kaur Dhanjal

Authors
  1. Manisha Goyal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sonam Grover
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jaspreet Kaur Dhanjal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sukriti Goyal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chetna Tyagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Abhinav Grover
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abhinav Grover.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 455 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goyal, M., Grover, S., Dhanjal, J.K. et al. Molecular modelling studies on flavonoid derivatives as dual site inhibitors of human acetyl cholinesterase using 3D-QSAR, pharmacophore and high throughput screening approaches. Med Chem Res 23, 2122–2132 (2014). https://doi.org/10.1007/s00044-013-0810-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-013-0810-2

Keywords

Search

Navigation